Resources and Evidence Contact us

132 Results:

Sort By:

Real-world data on human milk-based fortification reveals limitations of protocol designs of two RCTs

Type: Press Releases

Topic(s): Company

Prolacta's human milk-based nutrition has touched the lives of 100,000 Premature and Critically Ill Infants Globally

Type: Press Releases

Topic(s): Company

Prolacta Bioscience recognizes advances in preterm care during NICU awareness month

Type: Press Releases

Topic(s): Company

Prolacta Bioscience applauds Ohio legislature for supporting Medicaid reimbursement for donor human milk-derived products

Type: Press Releases

Topic(s): Legislative

New study shows Prolacta’s human milk-based nutritional fortifiers save hospital NICUs up to $3.4M annually

Type: Press Releases

Topic(s): Bronchopulmonary Dysplasia (BPD) Clinical Studies on Prolact/Humavant CR Cost Savings / Cost Effectiveness Length of hospital stay Necrotizing Entercolitis (NEC)

Study reveals Prolacta’s 100% human milk-based nutritional fortifiers significantly increase bioactive proteins and antioxidant activity in human milk samples, outperforming cow milk-based fortifier

Type: Press Releases

Topic(s): Clinical Studies Clinical Studies on Prolact/Humavant CR Company Growth Probiotics Product

Prolacta Bioscience celebrates donor moms on World Human Milk Donation Day

Type: Press Releases

Topic(s): Company Donors

Prolacta Bioscience recognizes contributions of breast milk donors during National Nutrition Month

Type: Press Releases

Topic(s): Company Parents

The Prolacta Bioscience Foundation empowers parents and communities with over half a million dollars in grant funding in 2022

Type: Press Releases

Topic(s): Company Parents

Not finding the reference you’re looking for?

Use our main search field or email us at info@prolacta.com